Page last updated: 2024-10-25

ciprofloxacin and Hypoxia

ciprofloxacin has been researched along with Hypoxia in 6 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.

Research Excerpts

ExcerptRelevanceReference
"Pneumonia and acute respiratory distress syndrome are life-threatening complications after pneumonectomy carrying high mortality."1.32Successful therapy of severe pneumonia-associated ARDS after pneumonectomy with ECMO and steroids. ( Dünser, M; Hasibeder, W; Mayr, AJ; Rieger, M, 2004)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Su, L1
Li, Y1
Tian, S1
Huang, F1
Ren, Y1
Yang, C1
van der Mei, HC1
Busscher, HJ1
Shi, L1
Li, JJ1
Hu, Y1
Hu, B1
Wang, W1
Xu, H1
Hu, XY1
Ding, F1
Li, HB1
Wang, KR1
Zhang, X1
Guo, DS1
Cardinale, F1
Chironna, M1
Dumke, R1
Binetti, A1
Daleno, C1
Sallustio, A1
Valzano, A1
Esposito, S1
Papanicolas, LE1
Holds, JM1
Bak, N1
Dünser, M1
Hasibeder, W1
Rieger, M1
Mayr, AJ1
Zuck, P1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Retrospective Study of Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome[NCT01423864]Phase 229 participants (Actual)Interventional2005-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

6 other studies available for ciprofloxacin and Hypoxia

ArticleYear
Synergy between pH- and hypoxia-responsiveness in antibiotic-loaded micelles for eradicating mature, infectious biofilms.
    Acta biomaterialia, 2022, Volume: 154

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Hydrogen-Ion Concentration; Hypoxia; Mice;

2022
Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer.
    Nature communications, 2022, 10-21, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Ciprofloxacin; Delayed-Action Preparations;

2022
Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia.
    The European respiratory journal, 2011, Volume: 37, Issue:6

    Topics: Anti-Bacterial Agents; C-Reactive Protein; Child; Ciprofloxacin; Community-Acquired Infections; Drug

2011
Meningitis and pneumonitis caused by pet rodents.
    The Medical journal of Australia, 2012, Feb-20, Volume: 196, Issue:3

    Topics: Adult; Animals; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Ciprofloxacin; Female; Fusob

2012
Successful therapy of severe pneumonia-associated ARDS after pneumonectomy with ECMO and steroids.
    The Annals of thoracic surgery, 2004, Volume: 78, Issue:1

    Topics: Anti-Inflammatory Agents; Bronchial Fistula; Carcinoma, Bronchogenic; Cilastatin; Ciprofloxacin; Com

2004
[The role of ciprofloxacin in the treatment of chronic bronchitis].
    Presse medicale (Paris, France : 1983), 1998, Mar-28, Volume: 27, Issue:12

    Topics: Acute Disease; Anti-Infective Agents; Bacterial Infections; Bronchitis; Chronic Disease; Ciprofloxac

1998